Longer follow up data on dose escalation for CB-011 CaMMouflage phase 1 clinical trial, EHA 2026 oral presentation

Caribou Biosciences Inc. published this content on June 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 11, 2026 at 12:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]